Hyperion Therapeutics Inc (NASDAQ:HPTX) Investor Alert: Acquisition Faces Investigation
An investigation on behalf of investors, who currently hold shares of Hyperion Therapeutics Inc (NASDAQ:HPTX), was announced concerning whether the takeover of Hyperion Therapeutics Inc by Horizon Pharma plc for $46.00 per share is unfair to NASDAQ:HPTX stockholders.
View full press release